Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

Clinical trial NCT07098988 · RECRUITING

Trial details

NCT number: NCT07098988
Sponsor: CatalYm GmbH
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Non-Squamous Non-Small Cell Lung Cancer Adult Solid Tumor

Start date: 2025-08-01
Primary completion: 2029-03-31
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.